Specialty Pharmacy

Portrazza plus chemotherapy treats metastatic squamous non-small cell lung cancer in patients who were not previously treated specifically for advanced lung cancer.

Secondary prevention found to be unavailable and unaffordable in 94,919 communities across the world.

Some of the basic research behind NS5B inhibitors reveals an often overlooked, but clinically important difference between Viekira Pak and Harvoni.

Increasing colon cancer awareness could exponentially decrease disease-related deaths.

Overall satisfaction with the total cost of health care has been stable for 14 years.

Novel oral treatment for moderate-to-severe plaque psoriasis deemed an effective option.

Novartis is paying $390 million to settle charges that it paid kickbacks to pharmacies to encourage drug sales.

Anxiety sensitivity has been linked to more debilitating asthma symptoms and greater functional limitations.

Opdivo found to improve overall survival compared with other leading cancer therapies.

Health care professionals can use app to access patient data through HIPAA-compliant dashboards on computers or tablets.

Pfizer and Allergan announce $160 billion merger, which is the second-largest in the healthcare industry's history and the largest to use a controversial tax-saving strategy.

Pharmacies are rated as some of the best places to receive top-notch customer service in America.

Tafinlar plus Mekinist found to improve overall survival in unresectable or metastatic BRAF-mutated melanoma.

Jon Hamrick, executive vice president, Biotech and Specialty Services at Therigy LLC, discusses techniques specialty pharmacies can use to improve workflow and clinical activities in therapy management.

Effective therapies in liver transplant patients reduces HCV recurrence.

App developers need to ensure mHealth apps are HIPAA-compliant by design.

CMS aims to provide choice and competition for consumers and improve the consumer experience.

Patients treated with HIV therapy less likely to get infected with HBV.

In addition to facing the risk of fatal overdose, kidney disease, and pneumonia, heroin users also have a greater likelihood of acquiring HIV.

Long-term care pharmacies' current prescription drug reimbursement model may not be sustainable, a new analysis suggests.

Concerns raised from combining medical marijuana dispensaries with recreational dispensaries.

Latest news in cancer drug development.

Patients treated with HIV therapy less likely to get infected with HBV.

Rollator produces highest walk distance and times in COPD patients.

Ixazomib is an oral proteasome inhibitor used in combination with lenalidomide and dexamethasone.

Patients on Medicaid more likely to have HCV infection and much more likely to be denied coverage.

Top stories of the week on Specialty Pharmacy Times.

Study suggests increasing oxidative stress through with pro-oxidants may prevent metastasis.